7 March 2023 - The FDA seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.

The company that makes Makena, the only drug aimed at preventing preterm birth, announced on Tuesday that it was voluntarily pulling the medication off the market after advisers for the FDA concluded that the treatment did not help pregnant women at all.

Read New York Times article